Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
22.27
-2.31 (-9.40%)
At close: Apr 23, 2026, 4:00 PM EDT
22.43
+0.16 (0.72%)
After-hours: Apr 23, 2026, 7:55 PM EDT
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $17.28 billion as of April 23, 2026. Its market cap has increased by 35.27% in one year.
Market Cap
17.28B
Enterprise Value
16.59B
1-Year Change
35.27%
Ranking
Category
Stock Price
$22.27
Market Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $17.28B, an increase of 14,423.78%. That is a compound annual growth rate of 56.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 19.06B | 46.38% |
| Dec 31, 2025 | 13.02B | -1.06% |
| Dec 31, 2024 | 13.16B | 619.43% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
| Mar 5, 2015 | 119.00M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revolution Medicines | 31.32B |
| Insmed | 30.43B |
| Royalty Pharma | 29.33B |
| BioNTech SE | 28.22B |
| Moderna | 21.51B |
| Roivant Sciences | 20.96B |
| Incyte | 19.15B |
| Genmab | 16.71B |